ART27.13 clinical trials

Determining the role of synthetic cannabinoids in eye pressure and tolerability measurements

This study is testing a new drug (ART27.13) for glaucoma. Glaucoma can damage eyesight by increasing pressure inside the eye. We want to see if ART27.13 can safely lower this eye pressure without the side effects of other similar drugs.